| Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients (NCT07725484) | Shanghai Zhongshan Hospital | 2026-11-01 |
| LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement (NCT07733076) | Shanghai Zhongshan Hospital | 2026-09-30 |
| Accuracy of 3D Electrical Impedance Tomography for Assessing Lung Ventilation (NCT07756086) | Shanghai Zhongshan Hospital | 2026-09-01 |
| A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants (NCT07671391) | Shanghai Zhongshan Hospital | 2026-08-01 |
| Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors (NCT07727317) | Shanghai Zhongshan Hospital | 2026-08-01 |
| A Prospective Observational Study Using the FAM-CAM (NCT07694687) | Shanghai Zhongshan Hospital | 2026-08-01 |
| The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study (NCT07724951) | Shanghai Zhongshan Hospital | 2026-07-31 |
| Impact of 3D-EIT-Guided Acapella Breathing Training on Lung Ventilation Distribution (NCT07733843) | Shanghai Zhongshan Hospital | 2026-07-31 |
| Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet) (NCT07714317) | Shanghai Zhongshan Hospital | 2026-07-20 |
| QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer (NCT07733115) | Shanghai Zhongshan Hospital | 2026-07-20 |
| Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation (NCT07677410) | Shanghai Zhongshan Hospital | 2026-07-18 |
| Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma (NCT07734857) | Shanghai Zhongshan Hospital | 2026-07-10 |
| EIT-Guided Visual Feedback During Incentive Spirometry for Postoperative Atelectasis (NCT07681232) | Shanghai Zhongshan Hospital | 2026-07-01 |
| Eye-Tracking Communication Tool for Non-verbal ICU Patients (NCT07205419) | Shanghai Zhongshan Hospital | 2026-07-01 |
| Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction (NCT07621380) | Shanghai Zhongshan Hospital | 2026-07-01 |
| HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma (NCT07685535) | Shanghai Zhongshan Hospital | 2026-06-30 |
| Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study) (NCT07634861) | Shanghai Zhongshan Hospital | 2026-06-20 |
| PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy (NCT07644208) | Shanghai Zhongshan Hospital | 2026-06-15 |
| Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis (NCT07602062) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC (NCT07353476) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment (NCT07508956) | Shanghai Zhongshan Hospital | 2026-06-01 |
| SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer (NCT07535632) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS (NCT07616037) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction (NCT07616024) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients (NCT07663253) | Shanghai Zhongshan Hospital | 2026-06-01 |
| AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study) (NCT07640906) | Shanghai Zhongshan Hospital | 2026-06-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). (NCT07638683) | Shanghai Zhongshan Hospital | 2026-05-22 |
| Safety and Efficacy of High-Channel Implanted BCI for Motor Function Improvement in Tetraplegia Patients (NCT07457645) | Shanghai Zhongshan Hospital | 2026-05-15 |
| Pulsed Field Ablation in the Coronary Sinus: Feasibility and Safety of a Novel Approach for Mitral Isthmus Block (NCT07577544) | Shanghai Zhongshan Hospital | 2026-05-15 |
| A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome (NCT07558538) | Shanghai Zhongshan Hospital | 2026-05-14 |
| Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer (NCT07529626) | Shanghai Zhongshan Hospital | 2026-05-11 |
| Study on the Measurement Method of the Left Diaphragm (NCT07559669) | Shanghai Zhongshan Hospital | 2026-05-05 |
| Impact of Hyperemic State on Angio-IMR Performance (NCT07613996) | Shanghai Zhongshan Hospital | 2026-05-04 |
| BBAP With CS Mapping Guidance (NCT07531368) | Shanghai Zhongshan Hospital | 2026-05-01 |
| Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer (NCT07614061) | Shanghai Zhongshan Hospital | 2026-05-01 |
| Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma (NCT07501104) | Shanghai Zhongshan Hospital | 2026-05-01 |
| Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease (NCT07570836) | Shanghai Zhongshan Hospital | 2026-04-30 |
| Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery (NCT07521787) | Shanghai Zhongshan Hospital | 2026-04-23 |
| A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery (NCT07518680) | Shanghai Zhongshan Hospital | 2026-04-10 |
| Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC) (NCT07545083) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma (NCT07517653) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Octreotide Microspheres for Preventing Pancreatic Fistula (NCT07479784) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation (NCT07487532) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes (NCT07528105) | Shanghai Zhongshan Hospital | 2026-04-01 |
| ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management (NCT07517042) | Shanghai Zhongshan Hospital | 2026-04-01 |
| CIED Post-OR Rehabilitation (NCT07494825) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Eye-Tracking Interactive Agent in Non-verbal ICU Patients (NCT07429695) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Triage and Recognition of Acute Aortic Dissection in Chest Pain by Electrocardiogram-Artificial Intelligence (NCT07536932) | Shanghai Zhongshan Hospital | 2026-04-01 |
| Prospective Observational Study of Exhaled Carbon MonoxideTrajectories and Outcomes in ICU Patients (NCT07454057) | Shanghai Zhongshan Hospital | 2026-03-15 |
| Accelerated LBBP for Patients With RHF and Severe TR (NCT07470047) | Shanghai Zhongshan Hospital | 2026-03-10 |
| Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma (NCT07570849) | Shanghai Zhongshan Hospital | 2026-03-01 |
| Machine Learning Prediction of Mortality After Prone Positioning in ARDS (NCT07445061) | Shanghai Zhongshan Hospital | 2026-03-01 |
| Fecal Molecular Susceptibility-guided Hp First-line Therapy (NCT07405684) | Shanghai Zhongshan Hospital | 2026-02-28 |
| Gelaspan vs Crystalloid Therapy in Sepsis (NCT07172451) | Shanghai Zhongshan Hospital | 2026-02-13 |
| A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke (NCT07396493) | Shanghai Zhongshan Hospital | 2026-02-08 |
| Efficacy of Montelukast on STEMl Patients (NCT07320625) | Shanghai Zhongshan Hospital | 2026-02-01 |
| A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital (NCT07400601) | Shanghai Zhongshan Hospital | 2026-02-01 |
| Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) (NCT07383142) | Shanghai Zhongshan Hospital | 2026-02-01 |
| Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07259473) | Shanghai Zhongshan Hospital | 2026-01-31 |
| Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study (NCT06794073) | Shanghai Zhongshan Hospital | 2026-01-31 |
| Cardiac Amyloidosis in Patients With Aortic Stenosis (NCT07170306) | Shanghai Zhongshan Hospital | 2026-01-31 |
| Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study (NCT07266025) | Shanghai Zhongshan Hospital | 2026-01-30 |
| The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients (NCT07380555) | Shanghai Zhongshan Hospital | 2026-01-30 |
| In Vivo CAR-T for Refractory Graves' Disease (NCT07333677) | Shanghai Zhongshan Hospital | 2026-01-29 |
| Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices (NCT07358663) | Shanghai Zhongshan Hospital | 2026-01-20 |
| Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer (NCT07365397) | Shanghai Zhongshan Hospital | 2026-01-19 |
| Heart Failure Center Accreditation in China (HF-CAP Trial) (NCT07371780) | Shanghai Zhongshan Hospital | 2026-01-01 |
| Exploring the Use of AI-Assisted Video Monitoring to Predict Accidental Events in ICU Patients (NCT07307521) | Shanghai Zhongshan Hospital | 2026-01-01 |
| A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer (NCT07333573) | Shanghai Zhongshan Hospital | 2026-01-01 |
| Prevention and Treatment of Early Postoperative Atelectasis Using The MetaNeb System in Patients Underwent Esophagectomy (NCT07284056) | Shanghai Zhongshan Hospital | 2026-01-01 |
| Effects of Inspiratory vs Expiratory Breath-Hold on Lung Perfusion Measured by EIT Saline Indicator Method: A Self-Controlled Study (NCT07303972) | Shanghai Zhongshan Hospital | 2026-01-01 |
| Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer (NCT07346807) | Shanghai Zhongshan Hospital | 2026-01-01 |
| Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS) (NCT07257380) | Shanghai Zhongshan Hospital | 2025-12-30 |
| A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma (NCT07309419) | Shanghai Zhongshan Hospital | 2025-12-22 |
| Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease (NCT07261345) | Shanghai Zhongshan Hospital | 2025-12-19 |
| Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents (NCT07307235) | Shanghai Zhongshan Hospital | 2025-12-13 |
| Asiaticoside for Treating Overweight/Obesity (NCT07241533) | Shanghai Zhongshan Hospital | 2025-12-01 |
| Valsalva SBP Drop and LVOT Obstruction (NCT07483125) | Shanghai Zhongshan Hospital | 2025-12-01 |
| Intravascular Imaging Evaluated Calcified Nodule China Registry (NCT07262359) | Shanghai Zhongshan Hospital | 2025-12-01 |
| EFG vs IVIG in TAMG (NCT07231523) | Shanghai Zhongshan Hospital | 2025-12-01 |
| A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST (NCT07208526) | Shanghai Zhongshan Hospital | 2025-12-01 |
| Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma (NCT07243951) | Shanghai Zhongshan Hospital | 2025-11-28 |
| Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms (NCT07272512) | Shanghai Zhongshan Hospital | 2025-11-11 |
| Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension (NCT07177703) | Shanghai Zhongshan Hospital | 2025-10-31 |
| Construction of a Portal Hypertension Biobank (NCT07419724) | Shanghai Zhongshan Hospital | 2025-10-16 |
| AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. (NCT07208539) | Shanghai Zhongshan Hospital | 2025-10-10 |
| Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study (NCT07206511) | Shanghai Zhongshan Hospital | 2025-10-09 |
| Autologous Islet Transplantation for Diabetes (NCT07118475) | Shanghai Zhongshan Hospital | 2025-10-07 |
| A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body (NCT07649382) | Shanghai Zhongshan Hospital | 2025-10-01 |
| A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava (NCT07162597) | Shanghai Zhongshan Hospital | 2025-10-01 |
| Association Between Blood Glucose Indicators and Heart Rate Variability in Non-diabetic Critically Ill Patients (NCT07198308) | Shanghai Zhongshan Hospital | 2025-10-01 |
| A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy (NCT07176702) | Shanghai Zhongshan Hospital | 2025-09-30 |
| Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection (NCT07156656) | Shanghai Zhongshan Hospital | 2025-09-01 |
| High-Resolution CT for Heart (NCT07169201) | Shanghai Zhongshan Hospital | 2025-09-01 |
| High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy (NCT07159022) | Shanghai Zhongshan Hospital | 2025-08-31 |
| µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions (NCT07116083) | Shanghai Zhongshan Hospital | 2025-08-13 |
| Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer (NCT07108504) | Shanghai Zhongshan Hospital | 2025-08-10 |
| Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease (NCT07129642) | Shanghai Zhongshan Hospital | 2025-08-10 |
| Observational Analysis of the Associational Between Dietary Factors and Postprandial Glucose Fluctuations (NCT07117188) | Shanghai Zhongshan Hospital | 2025-08-05 |
| Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer (NCT07096752) | Shanghai Zhongshan Hospital | 2025-08-01 |